Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article offers strategies for managing acne effectively and safely, emphasizing treatment optimization, patient tailoring, and addressing antimicrobial resistance, but reports no new clinical results.

In this case study, a 30-year-old postpartum woman with telogen effluvium saw marked improvement in hair regrowth and reduced hair fall following individualized homeopathic treatment, which reportedly addressed hormonal dysregulation, stress, and nutritional deficiency.

This retrospective study observed that telogen effluvium, a type of diffuse hair loss, frequently occurs in females aged 18–30 following SARS-CoV-2 infection, often accompanied by nutritional deficiencies, suggesting an association between COVID-19 and micronutrient deficiency, with acute cases being most common but chronic cases possible.

This study reported that 5% topical minoxidil lotion may be beneficial for enhancing hair regrowth in patients with telogen effluvium, although its effectiveness is limited by the self-healing nature of the condition and the small sample size.

In this study, Pilopeptan® Intensive, a nutritional supplement containing hydrolyzed collagen, Group B vitamins, and zinc, was found to significantly improve hair parameters in telogen effluvium patients, with sustained benefits observed posttreatment, although mild side effects were reported by some participants.

This study reports that intramuscular compound betamethasone may offer rapid, short-term reduction in hair shedding for patients with telogen effluvium, particularly within a week, but often requires repeated treatments; only mild side effects were observed.

This review examines how biochemical and biophysical induction factors influence cell fate in tissue engineering and reports no new experimental results.

This review discusses telogen effluvium, emphasizing its identifiable causes and treatment options, and reports no new clinical results.

This study found that a novel drinkable supplement significantly increased hair density and reduced hair shedding over six months in women with telogen effluvium, although the authors emphasize the need for larger, placebo-controlled trials to confirm these promising results.

This study found a significant association between glass ceiling syndrome and telogen effluvium in female health workers, suggesting that the stress from career barriers may contribute to hair loss, with education and occupational status also being related factors.

This study found that patients with alopecia, particularly alopecia areata and female pattern hair loss, often have vitamin D deficiency, suggesting that screening for vitamin D could benefit these patients.

This study observed that combining PRP and Tressfix Serum significantly improved hair regrowth and reduced microRNA expression linked to Chronic Telogen Effluvium compared to using either treatment alone.

This report describes a case where dermoscopy of shed hair helped diagnose post-COVID acute telogen effluvium by revealing depigmented club-shaped bulbs, highlighting its potential as a noninvasive diagnostic tool.

In this study, researchers found that the loss of SETDB1 in epidermal keratinocytes led to altered chromatin states, increased ERV expression, and activation of immune responses, while inhibiting these effects with certain antiviral drugs reduced skin inflammation and hair loss in a mouse model.

This study found that COVID-19 infection is a frequent cause of acute telogen effluvium, leading to excessive hair loss within 2–3 months after infection.

This case report documents a young girl who developed alopecia areata shortly after a COVID-19 infection, with significant hair regrowth achieved through topical treatment over six months, except for one resistant area; highlighting a potential link between the virus and autoimmune reactions.

This paper reviews the emerging role of FGF-7 signaling in hair regeneration, highlighting its potential as a target for new therapies despite limited clinical trial data.

This study found that in patients with telogen effluvium after recovering from COVID-19, earlier alopecia onset was associated with younger age, female gender, hypothyroidism, and more severe coronavirus infections.

This article highlights that hormonal changes during menopause can significantly affect hair health, leading to decreased hair density, altered texture, and increased hair disorders, which may subsequently impact emotional well-being in women.

This review discusses recent advances in stimuli-responsive nanoformulations for CRISPR-Cas9 delivery, highlighting their design rationales and potential biomedical applications, but reports no new experimental results.

In this literature review, it was reported that mental health disorders may both contribute to and be exacerbated by various types of hair loss, and an interdisciplinary treatment model is recommended for effective diagnosis and patient care.

This case report discusses a new onset of alopecia areata following reinfection with COVID-19, suggesting a potential link between COVID-19 infection and this hair loss condition.

In this study, chronic telogen effluvium and female pattern hair loss were the most common types of non-scarring diffuse hair loss among Indian women aged 15-45, with anemia frequently present across cases.

In this study, researchers developed a DNA/GelMA-based cryogel platform that uses phototherapy to combat MRSA infection and promote scarless wound healing, showing enhanced bactericidal activity, tissue regeneration, and anti-inflammatory effects in vivo, suggesting a promising approach for treating infected skin wounds.

This review examines the literature on autoimmune hair loss disorders, highlighting the collapse of immune privilege and the potential role of neurogenic stress in this process, but reports no new clinical results.

This review compiles current evidence on the molecular mechanisms, etiologies, and targeted immunotherapies for alopecia areata and reports no new experimental results, emphasizing the need for further research to manage the disease.

This review discusses how transposable element activation may hinder tissue regeneration and explores mechanisms to control this activity, reporting no new experimental results.

This report describes a case of acute telogen effluvium in a 38-year-old woman following recovery from COVID-19.

This cohort study found no overall increased risk of suicidal behaviors with finasteride versus dutasteride in men aged 50 and older, but suggested potential risk for those with a history of mood disorders.

This review indicates that glucagon-like peptide-1 receptor agonists may be linked to hair loss, raising safety concerns despite the lack of definitive causal evidence.